Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma

Oncotarget

Volumn 6, Issue 35, 2015, Pages 37028-37042

  Yan, Ting Ting ^a   Fu, Xue Liang ^a   Li, Jiao ^a   Bian, Ying Nan ^b   Liu, De Jun ^a   Hua, Rong ^a   Ren, Lin Lin ^a   Li, Cheng Tao ^b   Sun, Yong Wei ^a   Chen, Hao Yan ^a   Fang, Jing Yuan ^a   Hong, Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF FORENSIC SCIENCE   (China)

Author keywords

Biomarker; Metastasis; Pancreatic cancer; Pathology Section; PDAC; RPL15

Indexed keywords

FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NERVE CELL ADHESION MOLECULE; PROTEIN ZO1; RIBOSOMAL PROTEIN L15; RIBOSOME PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PLASMID; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE MICROARRAY; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CASE CONTROL STUDY; CELL PROLIFERATION; COHORT ANALYSIS; DISEASE COURSE; DRUG SCREENING; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL PROLIFERATION; COHORT STUDIES; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84947717376     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5939     Document Type: Article

References (35)

1. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK and Hruban RH. Recent progress in pancreatic cancer. CA: a cancer journal for clinicians. 2013; 63:318-348.
2. Siegel RL, Miller KD and Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015; 65:5-29.
3. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J. The incidences and mortalities of major cancers in China, 2009. Chinese journal of cancer. 2013; 32:106-112.
4. Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Nirodi CS, Piazza GA, Grizzle WE, Owen LB and Singh AP. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB-and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4. The Journal of biological chemistry. 2013; 288:21197-21207.
5. Sener SF, Fremgen A, Menck HR and Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. Journal of the American College of Surgeons. 1999; 189:1-7.
6. Kuramitsu Y, Taba K, Ryozawa S, Yoshida K, Zhang X, Tanaka T, Maehara S, Maehara Y, Sakaida I and Nakamura K. Identification of up-and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer research. 2010; 30:3367-3372.
7. Frank J. The ribosome-a macromolecular machine par excellence. Chemistry & biology. 2000; 7:R133-141.
8. Wu Q, Gou Y, Wang Q, Jin H, Cui L, Zhang Y, He L, Wang J, Nie Y, Shi Y and Fan D. Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PloS one. 2011; 6:e26401.
9. Gou Y, Shi Y, Zhang Y, Nie Y, Wang J, Song J, Jin H, He L, Gao L, Qiao L, Wu K and Fan D. Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochemical and biophysical research communications. 2010; 393:788-793.
10. Du J, Shi Y, Pan Y, Jin X, Liu C, Liu N, Han Q, Lu Y, Qiao T and Fan D. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer biology & therapy. 2005; 4:242-247.
11. Hegde V, Wang M and Deutsch WA. Human ribosomal protein S3 interacts with DNA base excision repair proteins hAPE/Ref-1 and hOGG1. Biochemistry. 2004; 43:14211-14217.
12. Landowski M, O'Donohue MF, Buros C, Ghazvinian R, Montel-Lehry N, Vlachos A, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Beggs AH, Gleizes PE and Gazda HT. Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Human genetics. 2013; 132:1265-1274.
13. Choe C, Cho YW, Kim CW, Son DS, Han J and Kang D. Identification of differentially expressed genes in bovine follicular cystic ovaries. The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2010; 14:265-272.
14. Wang Q, Yang C, Zhou J, Wang X, Wu M and Liu Z. Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene. 2001; 263:205-209.
15. Wang H, Zhao LN, Li KZ, Ling R, Li XJ and Wang L. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC cancer. 2006; 6:91.
16. Dang C, Gottschling M, Manning K, O'Currain E, Schneider S, Sterry W, Stockfleth E and Nindl I. Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncology reports. 2006; 16:513-519.
17. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z and Wang L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer cell. 2009; 16:259-266.
18. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR and Hussain SP. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PloS one. 2012; 7:e31507.
19. Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR and Hussain SP. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2013; 19:4983-4993.
20. Warner JR and McIntosh KB. How common are extraribosomal functions of ribosomal proteins? Molecular cell. 2009; 34:3-11.
21. Kenmochi N, Kawaguchi T, Rozen S, Davis E, Goodman N, Hudson TJ, Tanaka T and Page DC. A map of 75 human ribosomal protein genes. Genome research. 1998; 8:509-523.
22. Tom M, Waterman MR, Bocking D and Dauphin-Villemant C. Cloning and characterization of the L15 ribosomal protein gene homologue from the crayfish Orconectes limosus. Biochemical and biophysical research communications. 1999; 256:313-316.
23. Lee HS, Mun JH and Kim SG. Characterization of cDNAs encoding cytoplasmic ribosomal protein L15 and L27a in petunia (Petunia hybrida): primary structures and coordinate expression. Gene. 1999; 226:155-163.
24. Xiang Z, Zhang JN, Song P, Hu JR and Zhong Y. [The study of ribosomal protein l15 cDNA sequences as a molecular marker in the teleostei phylogenetic analysis]. Yi chuan = Hereditas/Zhongguo yi chuan xue hui bian ji. 2006; 28:171-178.
25. Zhang J, Gao FL, Zhi HY, Luo AP, Ding F, Wu M and Liu ZH. Expression patterns of esophageal cancer deregulated genes in C57BL/6J mouse embryogenesis. World journal of gastroenterology: WJG. 2004; 10:1088-1092.
26. Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, et al. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics: official journal of the DNA Methylation Society. 2012; 7:502-513.
27. Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M and Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Molecular cancer. 2014; 13:15.
28. Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan W, Sun Q, Xu J, Wu Z and Wu E. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Molecular cancer. 2013; 12:66.
29. Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P and Wang H. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer letters. 2014; 344:40-46.
30. Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X and Zhu M. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC cancer. 2013; 13:496.
31. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. The Journal of clinical investigation. 2009; 119:1438-1449.
32. Thiery JP, Acloque H, Huang RY and Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139:871-890.
33. Sun T, Du W, Xiong H, Yu Y, Weng Y, Ren L, Zhao H, Wang Y, Chen Y, Xu J, Xiang Y, Qin W, Cao W, Zou W, Chen H, Hong J, et al. TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014; 20:4689-4704.
34. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma XL and He B. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. European heart journal. 2013; 34:1834-1845.
35. Shan P, Pu J, Yuan A, Shen L, Chai D and He B. RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochemical and biophysical research communications. 2008; 375:628-633.